Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease.
Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease.
复制标题
患有稳定型冠状动脉疾病的 2 型糖尿病患者循环 IgE 和 CML 水平与支架内再狭窄的关系
DOI:
10.3390/jcdd9050157
复制
发表时间:
2022-05-13
影响因子:
2.4
通讯作者:
Wu, Liqun
中科院分区:
文献类型:
--
作者:
Liu, Jingmeng;Chen, Qiujing;Lu, Lin;Jin, Qi;Bao, Yangyang;Ling, Tianyou;Lin, Changjian;Ding, Fenghua;Wang, Xiaoqun;Shen, Weifeng;Shen, Ying;Dai, Yang;Wu, Liqun
关键词:
Background: We investigated whether serum levels of immunoglobin (Ig) E and Nε-carboxymethyl-lysine (CML) are related to in-stent restenosis (ISR) in patients with stable coronary artery disease and type 2 diabetes mellitus (T2DM). Methods: Serum levels of IgE and CML were measured in 196 ISR patients and 220 non-ISR patients with stable angina and T2DM who received angiographic follow-up 12 months after percutaneous coronary intervention (PCI) with third-generation drug-eluting stent (DES) implantation for de novo lesions. Multivariate logistic regression analysis was performed to assess the association between IgE or CML and ISR. Results: Both IgE and CML levels were higher in patients with ISR compared with non-ISR patients (IgE: 187.10 (63.75–489.65) vs. 80.25 (30.65–202.50), p < 0.001; CML: 203.26 (164.50–266.84) vs. 174.26 (130.85–215.56), p < 0.001). The rate of ISR increased stepwise with increasing tertiles of IgE and CML levels (p for all trends < 0.001), and IgE correlated significantly with CML. After adjusting for potential confounders, IgE and CML levels remained independently associated with ISR. Moreover, IgE and CML levels improved the predictive capability of traditional risk factors for ISR, and there existed an interaction between IgE and CML in relation to ISR (p for interaction < 0.01). Conclusion: Elevated circulating IgE and CML levels confer an increased risk for ISR after DES-based PCI in type 2 diabetic patients with stable coronary artery disease.
登录
查看更多内容
影响因子:
24
作者:
Carter, Paul;Lagan, Jakub;Miller, Christopher A.
通讯作者:
Miller, Christopher A.
影响因子:
24
作者:
Alfonso, Fernando;Byrne, Robert A.;Kastrati, Adnan
通讯作者:
Kastrati, Adnan
影响因子:
5.3
作者:
Guo, Xiaoxiao;Yuan, Su;Shen, Zhujun
通讯作者:
Shen, Zhujun
影响因子:
2.8
作者:
Han, Kaiyu;Suzukawa, Maho;Ohta, Ken
通讯作者:
Ohta, Ken
影响因子:
4.6
作者:
Kim MK;Jeong JS;Han K;Baek KH;Song KH;Kwon HS
通讯作者:
Kwon HS